PTC Therapeutics Inc. buy Wells Fargo & Company
Start price
08.12.23
/
50%
€24.20
Target price
08.12.24
€34.41
Performance (%)
40.50%
Price
13.06.24
€34.00
Summary
This prediction is currently active. With a performance of 40.50% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 4.762% | 4.762% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by Wells_Fargo___Compan for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $37.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat